GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (FRA:TG40) » Definitions » Piotroski F-Score

Oxurion NV (FRA:TG40) Piotroski F-Score : 4 (As of Dec. 12, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Oxurion NV Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Oxurion NV has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Oxurion NV's Piotroski F-Score or its related term are showing as below:

FRA:TG40' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 8
Current: 4

During the past 13 years, the highest Piotroski F-Score of Oxurion NV was 8. The lowest was 2. And the median was 4.


Oxurion NV Piotroski F-Score Historical Data

The historical data trend for Oxurion NV's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxurion NV Piotroski F-Score Chart

Oxurion NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 5.00 3.00 2.00 4.00

Oxurion NV Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.00 - 4.00 -

Competitive Comparison of Oxurion NV's Piotroski F-Score

For the Biotechnology subindustry, Oxurion NV's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxurion NV's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxurion NV's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Oxurion NV's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was €-18.97 Mil.
Cash Flow from Operations was €-9.77 Mil.
Revenue was €0.26 Mil.
Gross Profit was €0.10 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was (11.993 + 6.55) / 2 = €9.2715 Mil.
Total Assets at the begining of this year (Dec22) was €11.99 Mil.
Long-Term Debt & Capital Lease Obligation was €0.12 Mil.
Total Current Assets was €2.74 Mil.
Total Current Liabilities was €19.61 Mil.
Net Income was €-31.69 Mil.

Revenue was €0.60 Mil.
Gross Profit was €0.08 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was (18.876 + 11.993) / 2 = €15.4345 Mil.
Total Assets at the begining of last year (Dec21) was €18.88 Mil.
Long-Term Debt & Capital Lease Obligation was €4.07 Mil.
Total Current Assets was €7.11 Mil.
Total Current Liabilities was €12.35 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Oxurion NV's current Net Income (TTM) was -18.97. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Oxurion NV's current Cash Flow from Operations (TTM) was -9.77. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-18.969/11.993
=-1.58167264

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-31.685/18.876
=-1.67858656

Oxurion NV's return on assets of this year was -1.58167264. Oxurion NV's return on assets of last year was -1.67858656. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Oxurion NV's current Net Income (TTM) was -18.97. Oxurion NV's current Cash Flow from Operations (TTM) was -9.77. ==> -9.77 > -18.97 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=0.117/9.2715
=0.01261932

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=4.068/15.4345
=0.26356539

Oxurion NV's gearing of this year was 0.01261932. Oxurion NV's gearing of last year was 0.26356539. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=2.74/19.607
=0.13974601

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=7.106/12.349
=0.57543121

Oxurion NV's current ratio of this year was 0.13974601. Oxurion NV's current ratio of last year was 0.57543121. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Oxurion NV's number of shares in issue this year was 0.165. Oxurion NV's number of shares in issue last year was 0.009. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.104/0.263
=0.39543726

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.082/0.595
=0.13781513

Oxurion NV's gross margin of this year was 0.39543726. Oxurion NV's gross margin of last year was 0.13781513. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=0.263/11.993
=0.02192946

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=0.595/18.876
=0.03152151

Oxurion NV's asset turnover of this year was 0.02192946. Oxurion NV's asset turnover of last year was 0.03152151. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+1+0+0+1+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Oxurion NV has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Oxurion NV  (FRA:TG40) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Oxurion NV Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Oxurion NV's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxurion NV Business Description

Traded in Other Exchanges
Address
Gaston Geenslaan 1, Leuven, BEL, B-3001
Oxurion NV is a clinical-stage biopharmaceutical company developing next-generation standard-of-care ophthalmic therapies, which are designed to improve and preserve vision in patients with retinal disorders including Geographic Atrophy (GA). The Group's research and development facilities are located in Belgium. The Company is engaged in the development of drugs to treat blindness diseases.

Oxurion NV Headlines

No Headlines